Barclays Said to Lose About $100 Million on Failed Sobi Deal (3)

The collapse of an $8 billion biotech acquisition and a slump in the Swedish krona left Barclays Plc with a major loss last month.

The London-based bank lost about $100 million on currency hedges after the U.S. private equity firm Advent International and Singapore’s sovereign wealth fund GIC withdrew their bid for Swedish Orphan Biovitrum AB in December, people with knowledge of the matter said.

Morgan Stanley and Deutsche Bank AG also lost about $20 million each on the trades, the people said, asking not to be identified discussing private figures.

Spokespeople for Barclays, Deutsche Bank, Morgan Stanley and Advent ...